The role of methyl-CpG binding protein 2 in liver fibrosis

Toxicology

Volumn 309, Issue , 2013, Pages 9-14

  Bian, Er Bao ^a   Huang, Cheng ^a   Wang, Hua ^a   Chen, Xiao Xia ^a   Tao, Hui ^a   Zhang, Lei ^a   Lv, Xiong wen ^a   Li, Jun ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Hepatic stellate cell; Liver fibrosis; MeCP2; MicroRNA; Signaling pathway

Indexed keywords

METHYL CPG BINDING PROTEIN 2; MICRORNA; TRANSCRIPTION FACTOR EZH2;

GENE EXPRESSION; GENE TARGETING; LIVER FIBROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ANIMALS; HUMANS; LIVER CIRRHOSIS; METHYL-CPG-BINDING PROTEIN 2; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 84877818598     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2013.04.008     Document Type: Review

References (55)

1. Beisel C., Imhof A., Greene J., Kremmer E., Sauer F. Histone methylation by the Drosophila epigenetic transcriptional regulator Ash1. Nature 2002, 419:857-862.
2. Chahrour M., Jung S.Y., Shaw C., Zhou X., Wong S.T., Qin J., Zoghbi H.Y. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 2008, 320:1224-1229.
3. Cheutin T., McNairn A.J., Jenuwein T., Gilbert D.M., Singh P.B., Misteli T. Maintenance of stable heterochromatin domains by dynamic HP1 binding. Science 2003, 299:721-725.
4. Cohen S., Zhou Z., Greenberg M.E. Medicine. Activating a repressor. Science 2008, 320:1172-1173.
5. Dews M., Homayouni A., Yu D., Murphy D., Sevignani C., Wentzel E., Furth E.E., Lee W.M., Enders G.H., Mendell J.T., Thomas-Tikhonenko A. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat. Genet. 2006, 38:1060-1065.
6. Downward J. Role of receptor tyrosine kinases in G-protein-coupled receptor regulation of Ras: transactivation or parallel pathways?. Biochem. J. 2003, 376:e9-e10.
7. Elsharkawy A.M., Oakley F., Mann D.A. The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis. Apoptosis 2005, 10:927-939.
8. Friedman S.L. Transcriptional regulation of stellate cell activation. J. Gastroenterol. Hepatol. 2006, 21(Suppl. 3):S79-S83.
9. Friedman S.L. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol. Rev. 2008, 88:125-172.
10. Fuks F., Hurd P.J., Deplus R., Kouzarides T. The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase. Nucl. Acids Res. 2003, 31:2305-2312.
11. Fuks F., Hurd P.J., Wolf D., Nan X., Bird A.P., Kouzarides T. The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J. Biol. Chem. 2003, 278:4035-4040.
12. Gadalla K.K., Bailey M.E., Cobb S.R. MeCP2 and Rett syndrome: reversibility and potential avenues for therapy. Biochem. J. 2011, 439:1-14.
13. Gregory G.D., Vakoc C.R., Rozovskaia T., Zheng X., Patel S., Nakamura T., Canaani E., Blobel G.A. Mammalian ASH1L is a histone methyltransferase that occupies the transcribed region of active genes. Mol. Cell. Biol. 2007, 27:8466-8479.
14. Hansen J.C., Ghosh R.P., Woodcock C.L. Binding of the Rett syndrome protein, MeCP2, to methylated and unmethylated DNA and chromatin. IUBMB Life 2010, 62:732-738.
15. Hazra S., Miyahara T., Rippe R.A., Tsukamoto H. PPAR gamma and hepatic stellate cells. Comp. Hepatol. 2004, 3(Suppl. 1):S7.
16. He L., He X., Lim L.P., de Stanchina E., Xuan Z., Liang Y., Xue W., Zender L., Magnus J., Ridzon D., Jackson A.L., Linsley P.S., Chen C., Lowe S.W., Cleary M.A., Hannon G.J. A microRNA component of the p53 tumour suppressor network. Nature 2007, 447:1130-1134.
17. Hellerbrand C., Jobin C., Iimuro Y., Licato L., Sartor R.B., Brenner D.A. Inhibition of NFkappaB in activated rat hepatic stellate cells by proteasome inhibitors and an IkappaB super-repressor. Hepatology 1998, 27:1285-1295.
18. Hite K.C., Adams V.H., Hansen J.C. Recent advances in MeCP2 structure and function. Biochem. Cell Biol. 2009, 87:219-227.
19. Hu B., Gharaee-Kermani M., Wu Z., Phan S.H. Epigenetic regulation of myofibroblast differentiation by DNA methylation. Am. J. Pathol. 2010, 177:21-28.
20. Hu B., Gharaee-Kermani M., Wu Z., Phan S.H. Essential role of MeCP2 in the regulation of myofibroblast differentiation during pulmonary fibrosis. Am. J. Pathol. 2011, 178:1500-1508.
21. Jones P.L., Veenstra G.J., Wade P.A., Vermaak D., Kass S.U., Landsberger N., Strouboulis J., Wolffe A.P. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet. 1998, 19:187-191.
22. Kim V.N., Han J., Siomi M.C. Biogenesis of small RNAs in animals. Nat. Rev. Mol. Cell Biol. 2009, 10:126-139.
23. Klein M.E., Lioy D.T., Ma L., Impey S., Mandel G., Goodman R.H. Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA. Nat. Neurosci. 2007, 10:1513-1514.
24. Kogure T., Costinean S., Yan I., Braconi C., Croce C., Patel T. Hepatic miR-29ab1 expression modulates chronic hepatic injury. J. Cell. Mol. Med. 2012, 16:2647-2654.
25. Kolfschoten I.G., van Leeuwen B., Berns K., Mullenders J., Beijersbergen R.L., Bernards R., Voorhoeve P.M., Agami R. A genetic screen identifies PITX1 as a suppressor of RAS activity and tumorigenicity. Cell 2005, 121:849-858.
26. Kong X., Horiguchi N., Mori M., Gao B. Cytokines and STATs in liver fibrosis. Front. Physiol. 2012, 3:69.
27. Krol J., Loedige I., Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet. 2010, 11:597-610.
28. Kuzmichev A., Nishioka K., Erdjument-Bromage H., Tempst P., Reinberg D. Histone methyltransferase activity associated with a human multiprotein complex containing the enhancer of Zeste protein. Genes Dev. 2002, 16:2893-2905.
29. Lewis J.D., Meehan R.R., Henzel W.J., Maurer-Fogy I., Jeppesen P., Klein F., Bird A. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 1992, 69:905-914.
30. Liang G., Lin J.C., Wei V., Yoo C., Cheng J.C., Nguyen C.T., Weisenberger D.J., Egger G., Takai D., Gonzales F.A., Jones P.A. Distinct localization of histone H3 acetylation and H3-K4 methylation to the transcription start sites in the human genome. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:7357-7362.
31. Lujambio A., Calin G.A., Villanueva A., Ropero S., Sanchez-Cespedes M., Blanco D., Montuenga L.M., Rossi S., Nicoloso M.S., Faller W.J., Gallagher W.M., Eccles S.A., Croce C.M., Esteller M. A microRNA DNA methylation signature for human cancer metastasis. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:13556-13561.
32. Maher J.J. Interactions between hepatic stellate cells and the immune system. Semin. Liver Dis. 2001, 21:417-426.
33. Mann J., Chu D.C., Maxwell A., Oakley F., Zhu N.L., Tsukamoto H., Mann D.A. MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis. Gastroenterology 2010, 138:705-714. 714.e701-714.e704.
34. Mann J., Oakley F., Akiboye F., Elsharkawy A., Thorne A.W., Mann D.A. Regulation of myofibroblast transdifferentiation by DNA methylation and MeCP2: implications for wound healing and fibrogenesis. Cell Death Differ. 2007, 14:275-285.
35. Matarazzo M.R., De Bonis M.L., Strazzullo M., Cerase A., Ferraro M., Vastarelli P., Ballestar E., Esteller M., Kudo S., D'Esposito M. Multiple binding of methyl-CpG and polycomb proteins in long-term gene silencing events. J. Cell. Physiol. 2007, 210:711-719.
36. Nan X., Ng H.H., Johnson C.A., Laherty C.D., Turner B.M., Eisenman R.N., Bird A. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 1998, 393:386-389.
37. Oakley F., Mann J., Ruddell R.G., Pickford J., Weinmaster G., Mann D.A. Basal expression of IkappaBalpha is controlled by the mammalian transcriptional repressor RBP-J (CBF1) and its activator Notch1. J. Biol. Chem. 2003, 278:24359-24370.
38. Pauli A., Rinn J.L., Schier A.F. Non-coding RNAs as regulators of embryogenesis. Nat. Rev. Genet. 2011, 12:136-149.
39. Perugorria M.J., Wilson C.L., Zeybel M., Walsh M., Amin S., Robinson S., White S.A., Burt A.D., Oakley F., Tsukamoto H., Mann D.A., Mann J. Histone methyltransferase ASH1 orchestrates fibrogenic gene transcription during myofibroblast transdifferentiation. Hepatology 2012, 56:1129-1139.
40. Roderburg C., Urban G.W., Bettermann K., Vucur M., Zimmermann H., Schmidt S., Janssen J., Koppe C., Knolle P., Castoldi M., Tacke F., Trautwein C., Luedde T. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 2011, 53:209-218.
41. Schoeftner S., Sengupta A.K., Kubicek S., Mechtler K., Spahn L., Koseki H., Jenuwein T., Wutz A. Recruitment of PRC1 function at the initiation of X inactivation independent of PRC2 and silencing. EMBO J. 2006, 25:3110-3122.
42. Schwartz Y.B., Pirrotta V. Polycomb silencing mechanisms and the management of genomic programmes. Nat. Rev. Genet. 2007, 8:9-22.
43. Sekiya Y., Ogawa T., Yoshizato K., Ikeda K., Kawada N. Suppression of hepatic stellate cell activation by microRNA-29b. Biochem. Biophys. Res. Commun. 2011, 412:74-79.
44. Shahbazian M., Young J., Yuva-Paylor L., Spencer C., Antalffy B., Noebels J., Armstrong D., Paylor R., Zoghbi H. Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 2002, 35:243-254.
45. Singh J., Saxena A., Christodoulou J., Ravine D. MECP2 genomic structure and function: insights from ENCODE. Nucl. Acids Res. 2008, 36:6035-6047.
46. Suzuki M., Yamada T., Kihara-Negishi F., Sakurai T., Oikawa T. Direct association between PU.1 and MeCP2 that recruits mSin3A-HDAC complex for PU.1-mediated transcriptional repression. Oncogene 2003, 22:8688-8698.
47. Tao H., Huang C., Yang J.J., Ma T.T., Bian E.B., Zhang L., Lv X.W., Jin Y., Li J. MeCP2 controls the expression of RASAL1 in the hepatic fibrosis in rats. Toxicology 2011, 290:327-333.
48. Tseng Y.H., Butte A.J., Kokkotou E., Yechoor V.K., Taniguchi C.M., Kriauciunas K.M., Cypess A.M., Niinobe M., Yoshikawa K., Patti M.E., Kahn C.R. Prediction of preadipocyte differentiation by gene expression reveals role of insulin receptor substrates and necdin. Nat. Cell Biol. 2005, 7:601-611.
49. Urdinguio R.G., Fernandez A.F., Lopez-Nieva P., Rossi S., Huertas D., Kulis M., Liu C.G., Croce C.M., Calin G.A., Esteller M. Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome. Epigenetics 2010, 5:656-663.
50. Vetter M.L. Methylation gets SMRT. Functional insights into Rett syndrome. Dev. Cell 2003, 5:359-360.
51. Whelan J.T., Hollis S.E., Cha D.S., Asch A.S., Lee M.H. Post-transcriptional regulation of the Ras-ERK/MAPK signaling pathway. J. Cell. Physiol. 2012, 227:1235-1241.
52. Yang M.D., Chiang Y.M., Higashiyama R., Asahina K., Mann D.A., Mann J., Wang C.C., Tsukamoto H. Rosmarinic acid and baicalin epigenetically derepress peroxisomal proliferator-activated receptor gamma in hepatic stellate cells for their antifibrotic effect. Hepatology 2012, 55:1271-1281.
53. Yavrom S., Chen L., Xiong S., Wang J., Rippe R.A., Tsukamoto H. Peroxisome proliferator-activated receptor gamma suppresses proximal alpha1(I) collagen promoter via inhibition of p300-facilitated NF-I binding to DNA in hepatic stellate cells. J. Biol. Chem. 2005, 280:40650-40659.
54. Zachariah R.M., Rastegar M. Linking epigenetics to human disease and Rett syndrome: the emerging novel and challenging concepts in MeCP2 research. Neural Plast. 2012, 2012:415825.
55. Zhu N.L., Wang J., Tsukamoto H. The necdin-Wnt pathway causes epigenetic peroxisome proliferator-activated receptor gamma repression in hepatic stellate cells. J. Biol. Chem. 2010, 285:30463-30471.